Location History:
- Dexter, MI (US) (2005 - 2007)
- Mystic, CT (US) (2011 - 2014)
- Concord, MA (US) (2014 - 2020)
Company Filing History:
Years Active: 2005-2020
Title: Innovations of Douglas Scott Johnson: Pioneering Research in MAGL Inhibitors
Introduction
Douglas Scott Johnson, based in Concord, MA, is a prominent inventor with a significant portfolio that includes 12 patents. His work primarily focuses on the development of innovative compounds, particularly in the pharmaceutical field, aiming to address various medical disorders.
Latest Patents
Among his latest patents are the 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives. These compounds are designed as MAGL (monoglyceride lipase) inhibitors, which play a crucial role in treating MAGL-mediated diseases and disorders. His inventions provide compounds of Formula I and pharmaceutically acceptable salts thereof, alongside processes for their preparation and their potential therapeutic applications in treating conditions such as pain, inflammatory disorders, traumatic brain injuries, depression, anxiety, Alzheimer's disease, metabolic disorders, stroke, and cancer.
Career Highlights
Douglas has collaborated with notable companies in the pharmaceutical industry, including Pfizer Corporation and Warner-Lambert Company. His impressive career reflects a commitment to advancing scientific knowledge and therapeutic options for serious health issues.
Collaborations
Throughout his career, Douglas has had the privilege to work alongside talented individuals such as Patrick Robert Verhoest and Martin Youngjin Pettersson, enhancing the collaborative nature of his research and innovation efforts.
Conclusion
Douglas Scott Johnson's contributions to the field of pharmaceuticals through his innovative patents and collaborations demonstrate his role as a pivotal inventor in developing new treatments for various medical conditions. His ongoing research promises to continue making a significant impact on healthcare.